14 research outputs found
Prognostic value of serum carbohydrate 19-9 in patients receiving gemcitabine-based neoadjuvant therapy for pancreatic cancer.
No full textEffects of dose reduction on gemcitabine-based neoadjuvant chemoradiotherapy for localized pancreatic cancer.
No full text
Brain Metastases from Colorectal Cancer: Risk Factors, Incidence, and the Possible Role of Chemokines
No full textCost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial
No full textCharacterization of Subvisible Particles in Biotherapeutic Prefilled Syringes: The Role of Polysorbate and Protein on the Formation of Silicone Oil and Protein Subvisible Particles After Drop Shock
No full textEffect of Initiating a Multidisciplinary Care Clinic on Access and Time to Treatment in Patients With Pancreatic Adenocarcinoma
No full textThe establishment of a multidisciplinary pancreas tumor clinic led to improved patient access to consultations and shorter time to initial treatment in patients with pancreatic adenocarcinoma undergoing neoadjuvant therapy
